Absorbed dose to the fetus during bone scintigraphy
The authors observed the uptake of radiopharmaceutical and calculated absorbed dose in fetuses of two patients who underwent bone scintigraphy with technetium-99m methylene diphosphonate. Dose estimates per administered activity were 17 mrad/mCi (4.6 microGy/MBq) for an 8-week-old fetus and 9.7 mrad/mCi (2.6 microGy/MBq) for an 18-week-old fetus. Neither fetus demonstrated radionuclide uptake above maternal background levels. The uterine activity showed rapid clearance, with an effective half-life of 12 minutes after reaching a maximum within 1 minute after injection. Major contribution to fetal dose comes from the presence of the radionuclide in the maternal bladder. The authors conclude that bone scintigraphy performed unknowingly in pregnant individuals presents negligible increased risk to the fetus.
- Research Organization:
- Aultman Hospital, Canton, OH (USA)
- OSTI ID:
- 6859128
- Journal Information:
- Radiology; (United States), Journal Name: Radiology; (United States) Vol. 168:1; ISSN RADLA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Uptake of /sup 65/Zn in the mouse fetus as a function of gestational age
Radiation-induced abnormality and growth disturbance in the mouse fetus
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL HALF-LIFE
BODY
COUNTING TECHNIQUES
DIAGNOSTIC TECHNIQUES
DOSES
FEMALE GENITALS
FETUSES
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
ISOMERIC NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PATIENTS
PREGNANCY
RADIATION DOSES
RADIOISOTOPE SCANNING
RADIOISOTOPES
RISK ASSESSMENT
SCINTISCANNING
SKELETON
TECHNETIUM 99
TECHNETIUM ISOTOPES
UTERUS
YEARS LIVING RADIOISOTOPES